Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-05-04 @ 8:08 PM
Study NCT ID:
NCT04923620
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2021-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
Sponsor:
Shanghai Minimally Invasive Surgery Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MISC-Cet-FOLFOX-SCRT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None